Nothing Special   »   [go: up one dir, main page]

Chang et al., 2015 - Google Patents

Virally mediated Kcnq1 gene replacement therapy in the immature scala media restores hearing in a mouse model of human Jervell and Lange‐Nielsen deafness …

Chang et al., 2015

View PDF
Document ID
12654872074883467295
Author
Chang Q
Wang J
Li Q
Kim Y
Zhou B
Wang Y
Li H
Lin X
Publication year
Publication venue
EMBO molecular medicine

External Links

Snippet

Mutations in the potassium channel subunit KCNQ 1 cause the human severe congenital deafness Jervell and Lange‐Nielsen (JLN) syndrome. We applied a gene therapy approach in a mouse model of JLN syndrome (Kcnq1−/− mice) to prevent the development of …
Continue reading at www.embopress.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates

Similar Documents

Publication Publication Date Title
Chang et al. Virally mediated Kcnq1 gene replacement therapy in the immature scala media restores hearing in a mouse model of human Jervell and Lange‐Nielsen deafness syndrome
Xiong et al. AAV cis-regulatory sequences are correlated with ocular toxicity
György et al. Gene transfer with AAV9-PHP. B rescues hearing in a mouse model of usher syndrome 3A and transduces hair cells in a non-human primate
Suzuki et al. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Tan et al. Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors
JP7448953B2 (en) Cross-references to cell models and therapeutic applications for eye diseases
Geng et al. Modeling and preventing progressive hearing loss in Usher syndrome III
Liu et al. Specific and efficient transduction of Cochlear inner hair cells with recombinant adeno-associated virus type 3 vector
Shibata et al. RNA interference prevents autosomal-dominant hearing loss
Chien et al. Cochlear gene transfer mediated by adeno‐associated virus: Comparison of two surgical approaches
Shu et al. Identification of adeno-associated viral vectors that target neonatal and adult mammalian inner ear cell subtypes
Ruitenberg et al. Viral vector-mediated gene expression in olfactory ensheathing glia implants in the lesioned rat spinal cord
Pawlyk et al. Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosa
Xiao et al. Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor
Mao et al. Long-term rescue of retinal structure and function by rhodopsin RNA replacement with a single adeno-associated viral vector in P23H RHO transgenic mice
Cereso et al. Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient
Wang et al. Early postnatal virus inoculation into the scala media achieved extensive expression of exogenous green fluorescent protein in the inner ear and preserved auditory brainstem response thresholds
Yungher et al. Viral vector-based improvement of optic nerve regeneration: characterization of individual axons’ growth patterns and synaptogenesis in a visual target
Miwa et al. Mouse otocyst transuterine gene transfer restores hearing in mice with connexin 30 deletion-associated hearing loss
Askou et al. Reduction of choroidal neovascularization in mice by adeno‐associated virus‐delivered anti‐vascular endothelial growth factor short hairpin RNA
May-Simera et al. Loss of MACF1 abolishes ciliogenesis and disrupts apicobasal polarity establishment in the retina
BR112020016919A2 (en) COMPOSITIONS AND METHODS FOR TREATING HEARING DISABILITY NOT ASSOCIATED WITH AGE IN A HUMAN SUBJECT
Venkatesh et al. Retinal gene delivery by rAAV and DNA electroporation
Omichi et al. Hair cell transduction efficiency of single-and dual-AAV serotypes in adult murine cochleae
Bouaita et al. Downregulation of apoptosis-inducing factor in Harlequin mice induces progressive and severe optic atrophy which is durably prevented by AAV2-AIF1 gene therapy